How Cannabis Brands Can Navigate Vape Supply Chain Disruptions

How Cannabis Brands Can Navigate Vape Supply Chain Disruptions

Author: Cannabis Radio August 21, 2024 Duration: 35:08

Pete Sahani, the newly appointed CEO of the Blinc Group, is at the forefront of several groundbreaking initiatives aimed at addressing challenges within the cannabis vaping industry. One of the key strategies introduced under his leadership is a revamped supply chain system designed to mitigate issues faced by smaller companies due to long lead times and international shipping disruptions. This innovative strategy allows customers to order smaller quantities without the burden of large deposits or extended wait times. By maintaining a live inventory in the US, the Blinc Group offers a more responsive and flexible supply chain, ensuring a 60-day supply buffer based on customer needs. This approach not only improves inventory management but also significantly enhances customer satisfaction by providing more reliable and timely access to products.

Sahani has placed a strong emphasis on vape safety and compliance, reinforcing the Blinc Group’s commitment to setting industry standards. The company is actively involved in the Wave Safer initiative, advocating for stringent regulatory standards to ensure the highest levels of product safety and quality. By utilizing ISO and GMP certified suppliers, the Blinc Group underscores its dedication to producing vaping products that are safe, reliable, and of superior quality. This commitment to compliance and safety is crucial in maintaining the trust and loyalty of their customer base, as well as in distinguishing their products in a competitive market.


DOWNLOAD OUR NEWEST EBOOK.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

There’s a lot more to the cannabis industry than what grows in the field. Blunt Business, from Cannabis Radio, digs into the complex reality of building and running a company in this fast-moving space. We’re talking about the real work behind the scenes-supply chain logistics, regulatory hurdles, branding in a crowded market, and managing teams in a unique cultural environment. Each episode brings together voices who are actually doing the job, from executives steering multi-state operations to entrepreneurs who just opened their first dispensary. You’ll hear candid roundtable discussions where strategies are debated, and interviews that get into the specifics of leadership and finance without the hype. This isn’t about advocacy or culture; it’s a practical look at the mechanics of a profitable, high-stakes business. Tune in for a podcast that cuts through the smoke and offers tangible insights you can apply, whether you’re an investor, a manager, or building your own venture from the ground up.
Author: Language: English Episodes: 100

Blunt Business
Podcast Episodes
A Psychedelic and Cannabis Research Revolution On the Horizon? [not-audio_url] [/not-audio_url]

Duration: 29:28
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental h…
4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge? [not-audio_url] [/not-audio_url]

Duration: 24:45
As the legal landscape evolves, the traditional 4/20 retail boom is showing signs of cooling, with some markets seeing higher sales during the surrounding week than on the holiday itself due to aggressive discounting and…
Inside New York’s Five-Year Cannabis Chronicle [not-audio_url] [/not-audio_url]

Duration: 29:51
In this episode of The Blunt Business, the discussion dives deep into the complex landscape of the New York cannabis market as it hits its five-year legalization anniversary. While Governor Kathy Hochul lauds the state’s…
The Cannabis Business CLIMB or Cannabis for Healthy Livers [not-audio_url] [/not-audio_url]

Duration: 17:24
Blunt Business dives into the shifting landscape of American cannabis, from the halls of Congress to the microscopic world of medical research. We break down the newly proposed CLIMB Act, a bipartisan bill aimed at final…